Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provit...
Yifan Pharmaceutical reported revenue of 5.16 billion CNY for fiscal year 2024, up 26.8% from fiscal year 2023, and net income of 385.97 million CNY. In Q2 2025 (the quarter ended June 30, 2025) revenue was 1.31 billion CNY, up 0.2% from a year before. Its largest business segment, Pharmaceutical Products Division, brought in 85% of segment revenue in fiscal year 2025; China was the largest region with 77%.
Figures from company filings; latest fiscal year ended December 31, 2024.
No profile data available.